Michael Mina

544 total citations
12 papers, 244 citations indexed

About

Michael Mina is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Michael Mina has authored 12 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 6 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Michael Mina's work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Michael Mina is often cited by papers focused on Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Michael Mina collaborates with scholars based in Australia, United Kingdom and Singapore. Michael Mina's co-authors include Andrew R. Lloyd, Barbara Cameron, Jeffrey J. Post, Anthony Jaworowski, Megan Crane, Martyn A. French, Jingling Zhou, Christina C. Chang, Sharon R. Lewin and Rowena A. Bull and has published in prestigious journals such as Journal of Hepatology, Immunological Reviews and The Lancet Infectious Diseases.

In The Last Decade

Michael Mina

12 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Mina Australia 7 129 91 67 40 35 12 244
Abdulkarim Alhetheel Saudi Arabia 12 164 1.3× 79 0.9× 56 0.8× 58 1.4× 15 0.4× 35 315
Luna Colagrossi Italy 11 145 1.1× 197 2.2× 112 1.7× 23 0.6× 21 0.6× 35 331
Ann H. Wong China 13 216 1.7× 233 2.6× 31 0.5× 20 0.5× 33 0.9× 21 417
Jaiprasath Sachithanandham United States 10 240 1.9× 93 1.0× 18 0.3× 38 0.9× 25 0.7× 36 358
Phu Dac Tran Vietnam 8 102 0.8× 259 2.8× 207 3.1× 41 1.0× 39 1.1× 13 420
János Szlávik Hungary 10 164 1.3× 70 0.8× 17 0.3× 80 2.0× 16 0.5× 35 328
Caroline van den Ende Netherlands 8 113 0.9× 126 1.4× 36 0.5× 20 0.5× 32 0.9× 11 321
Myriam Ben Mamou Denmark 10 86 0.7× 267 2.9× 73 1.1× 58 1.4× 17 0.5× 17 319
Pieter L.A. Fraaij Netherlands 8 103 0.8× 126 1.4× 15 0.2× 31 0.8× 9 0.3× 12 225

Countries citing papers authored by Michael Mina

Since Specialization
Citations

This map shows the geographic impact of Michael Mina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mina more than expected).

Fields of papers citing papers by Michael Mina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Mina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mina. The network helps show where Michael Mina may publish in the future.

Co-authorship network of co-authors of Michael Mina

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Mina. A scholar is included among the top collaborators of Michael Mina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Mina. Michael Mina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Nicholson, Suellen, Rowena A. Bull, Marianne Martinello, et al.. (2023). Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19. Microorganisms. 11(8). 1985–1985. 1 indexed citations
2.
Hay, James A., David Haw, William P. Hanage, C. Jessica E. Metcalf, & Michael Mina. (2020). Implications of the Age Profile of the Novel Coronavirus. Digital Access to Scholarship at Harvard (DASH) (Harvard University). 3 indexed citations
3.
Mina, Michael, Alexander P. Underwood, Auda A. Eltahla, et al.. (2020). Anti‐envelope antibody responses in highly exposed seronegative individuals may be associated with protection from HCV infection. Journal of Viral Hepatitis. 27(10). 1012–1021. 1 indexed citations
4.
Walker, Melanie R., Auda A. Eltahla, Michael Mina, et al.. (2020). Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus Infection. Viruses. 12(1). 75–75. 17 indexed citations
5.
Clapham, Hannah, James A. Hay, Isobel Routledge, et al.. (2020). Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity. Emerging infectious diseases. 26(9). 1978–1986. 46 indexed citations
6.
Mina, Michael, et al.. (2016). Hepatitis C in Australian prisons: a national needs assessment. International Journal of Prisoner Health. 12(1). 3–16. 11 indexed citations
7.
Mina, Michael, et al.. (2016). Natural killer cells in highly exposed hepatitis C‐seronegative injecting drug users. Journal of Viral Hepatitis. 23(6). 464–472. 3 indexed citations
8.
Mina, Michael, Fabio Luciani, Barbara Cameron, et al.. (2015). Resistance to hepatitis C virus: potential genetic and immunological determinants. The Lancet Infectious Diseases. 15(4). 451–460. 18 indexed citations
9.
Cameron, Barbara, et al.. (2014). Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users. Journal of Hepatology. 61(4). 738–745. 16 indexed citations
10.
Mina, Michael, et al.. (2014). Enhancing hepatitis C treatment in the custodial setting: a national roadmap. The Medical Journal of Australia. 200(1). 15–16. 12 indexed citations
11.
Chang, Christina C., Megan Crane, Jingling Zhou, et al.. (2013). HIVand co‐infections. Immunological Reviews. 254(1). 114–142. 115 indexed citations
12.
Mina, Michael. (2011). Blood-Borne Viruses in New South Wales Prisons: Results from a Multi-Centre Study in Australia. Journal of Infection. 63(6). e3–e3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026